Cargando…
Does Extended Use of Clopidogrel-Based Dual Anti-Platelet Therapy Increase the Risk of Gastrointestinal Bleeding?
BACKGROUND: Clopidogrel-based dual anti-platelet therapy (CDAPT) has shown significant benefits in the management of coronary artery disease (CAD), up to 1-year duration. Gastrointestinal bleeding (GIB) is one of the limiting factors for prolonged use of CDAPT. METHODS: We identified all patients ta...
Autores principales: | Abbas, Hafsa, Kumar Nayudu, Suresh, Ravi, Madhavi, Saad, Muhammad, Bathini, Kashyap, Ravi, Pranav, Roy, Swathi, Arya, Divya, Chilimuri, Sridhar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433374/ https://www.ncbi.nlm.nih.gov/pubmed/32864025 http://dx.doi.org/10.14740/gr1285 |
Ejemplares similares
-
The Incidence and Mortality Impact of Gastrointestinal Bleeding in Hospitalized COVID-19 Patients
por: Makker, Jasbir, et al.
Publicado: (2021) -
Role of Transcatheter Arterial Embolization in Acute Refractory Non-variceal Upper Gastrointestinal Bleeding Not Controlled by Endoscopy: A Single-Center Experience and a Literature Review
por: Ishak, Charbel, et al.
Publicado: (2022) -
Transient Left Bundle Branch Block due to Severe Hyperkalemia
por: Kumar, Kishore, et al.
Publicado: (2017) -
Prevalence of advanced liver fibrosis and steatosis in type-2 diabetics with normal transaminases: A prospective cohort study
por: Makker, Jasbir, et al.
Publicado: (2021) -
Prognostic Value of AIMS65 Score in Cirrhotic Patients with Upper Gastrointestinal Bleeding
por: Gaduputi, Vinaya, et al.
Publicado: (2014)